⌘K
t
Dr. Martens plc announced that on 15 April 2026, restricted stock units granted to its Chief Executive Officer and PDMR, Ije Nwokorie, vested, leading to the acquisition of 432,625 Ordinary shares of GBP 0.01. On the same date, 204,051 of these shares were sold on his behalf at a price of £0.6555 per share to cover tax and national insurance liabilities.
| Date | 16 Apr 2026 |
| Time | 07:00:04 |
| Category | Director/PDMR dealings |
| ID | 6483A |
Dr. Martens plc
Director/PDMR Shareholding
Notification of Transactions by Director/Person Discharging Managerial Responsibility
Dr. Martens plc (the 'Company') announces that it has been notified of the following transaction(s) in the Company's Ordinary 1p shares undertaken on behalf of a director and person discharging managerial responsibility ('PDMR').
On 15 April 2026, a tranche of restricted stock units ('RSUs') granted to Ije Nwokorie under the Company's Long Term Incentive Plan ('LTIP') prior to his appointment as Chief Executive Officer vested and sufficient shares were subsequently sold on his behalf to cover his consequent tax and national insurance liabilities.
This tranche constitutes a portion of the RSU award which was granted to Ije on 14 June 2024 in lieu of outstanding incentive awards he forfeited on leaving his previous employer (the Award). The Award was made pursuant to the buyout arrangements agreed to secure Ije's recruitment to his previous role as Chief Brand Officer, which he held from February 2024 until he became Chief Executive Officer in January 2025, and in line with the stipulations of the Company's Remuneration Policy that 'buyout awards' be granted on a like-for-like basis to the extent possible. Full details of awards made to Ije under the LTIP will be disclosed in the Directors' Remuneration Report within the FY26 Annual Report, scheduled to be published in June 2026.
The relevant notifications, set out below, are provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
a) |
Name |
Ije Nwokorie |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR (Chief Executive Officer) |
||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Dr. Martens plc |
||||
|
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 |
||||
|
b) |
Nature of the transaction |
Acquisition of shares following vesting of restricted stock units |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information
|
N/A - single transaction |
||||
|
e) |
Date of the transaction |
15 April 2026 |
||||
|
f) |
Place of the transaction |
Outside a trading venue |
||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
a) |
Name |
Ije Nwokorie |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR (Chief Executive Officer) |
||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Dr. Martens plc |
||||
|
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 |
||||
|
b) |
Nature of the transaction |
Sale of sufficient shares acquired from vesting of restricted stock units to cover tax and national insurance liabilities. |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information
|
N/A - single transaction |
||||
|
e) |
Date of the transaction |
15 April 2026 |
||||
|
f) |
Place of the transaction |
XLON |
||||